Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

1.

A peptide antagonist of the ErbB1 receptor inhibits receptor activation, tumor cell growth and migration in vitro and xenograft tumor growth in vivo.

Xu R, Povlsen GK, Soroka V, Bock E, Berezin V.

Cell Oncol. 2010 Jan 1;32(4):259-74. doi: 10.3233/CLO-2010-0515.

PMID:
20364069
[PubMed - indexed for MEDLINE]
2.

Identification of a novel antagonist of the ErbB1 receptor capable of inhibiting migration of human glioblastoma cells.

Staberg M, Riemer C, Xu R, Dmytriyeva O, Bock E, Berezin V.

Cell Oncol (Dordr). 2013 Jun;36(3):201-11. doi: 10.1007/s13402-013-0128-6. Epub 2013 Apr 12.

PMID:
23580313
[PubMed - indexed for MEDLINE]
3.

Disabling receptor ensembles with rationally designed interface peptidomimetics.

Berezov A, Chen J, Liu Q, Zhang HT, Greene MI, Murali R.

J Biol Chem. 2002 Aug 2;277(31):28330-9. Epub 2002 May 14.

PMID:
12011054
[PubMed - indexed for MEDLINE]
Free Article
4.

Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.

Maegawa M, Takeuchi K, Funakoshi E, Kawasaki K, Nishio K, Shimizu N, Ito F.

Mol Cancer Res. 2007 Apr;5(4):393-401.

PMID:
17426253
[PubMed - indexed for MEDLINE]
Free Article
5.

Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway.

Sakai K, Yokote H, Murakami-Murofushi K, Tamura T, Saijo N, Nishio K.

Cancer Sci. 2007 Sep;98(9):1498-503. Epub 2007 Jul 11.

PMID:
17627612
[PubMed - indexed for MEDLINE]
6.

Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors.

Amin DN, Hida K, Bielenberg DR, Klagsbrun M.

Cancer Res. 2006 Feb 15;66(4):2173-80.

PMID:
16489018
[PubMed - indexed for MEDLINE]
Free Article
7.

AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.

Traxler P, Allegrini PR, Brandt R, Brueggen J, Cozens R, Fabbro D, Grosios K, Lane HA, McSheehy P, Mestan J, Meyer T, Tang C, Wartmann M, Wood J, Caravatti G.

Cancer Res. 2004 Jul 15;64(14):4931-41.

PMID:
15256466
[PubMed - indexed for MEDLINE]
Free Article
8.
9.

Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade.

Wu W, Onn A, Isobe T, Itasaka S, Langley RR, Shitani T, Shibuya K, Komaki R, Ryan AJ, Fidler IJ, Herbst RS, O'Reilly MS.

Mol Cancer Ther. 2007 Feb;6(2):471-83.

PMID:
17308046
[PubMed - indexed for MEDLINE]
Free Article
10.

The ErbB/HER receptor protein-tyrosine kinases and cancer.

Roskoski R Jr.

Biochem Biophys Res Commun. 2004 Jun 18;319(1):1-11. Review.

PMID:
15158434
[PubMed - indexed for MEDLINE]
11.

The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.

Motoyama AB, Hynes NE, Lane HA.

Cancer Res. 2002 Jun 1;62(11):3151-8.

PMID:
12036928
[PubMed - indexed for MEDLINE]
Free Article
12.

Epidermal growth factor mutant with wild-type affinity for both ErbB1 and ErbB3.

Wingens M, Jacobs-Oomen S, van der Woning SP, Stortelers C, van Zoelen EJ.

Biochemistry. 2006 Apr 11;45(14):4703-10.

PMID:
16584205
[PubMed - indexed for MEDLINE]
13.

Negative constraints underlie the ErbB specificity of epidermal growth factor-like ligands.

van der Woning SP, van Rotterdam W, Nabuurs SB, Venselaar H, Jacobs-Oomen S, Wingens M, Vriend G, Stortelers C, van Zoelen EJ.

J Biol Chem. 2006 Dec 29;281(52):40033-40. Epub 2006 Oct 10.

PMID:
17032651
[PubMed - indexed for MEDLINE]
Free Article
14.

Suramin inhibits the growth of non-small-cell lung cancer cells that express the epidermal growth factor receptor.

Fujiuchi S, Ohsaki Y, Kikuchi K.

Oncology. 1997 Mar-Apr;54(2):134-40.

PMID:
9075785
[PubMed - indexed for MEDLINE]
15.

Cell death induced by TNF or serum starvation is independent of ErbB receptor signaling in MCF-7 breast carcinoma cells.

Egeblad M, Jäättelä M.

Int J Cancer. 2000 Jun 1;86(5):617-25.

PMID:
10797281
[PubMed - indexed for MEDLINE]
16.

Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo.

Preet A, Ganju RK, Groopman JE.

Oncogene. 2008 Jan 10;27(3):339-46. Epub 2007 Jul 9.

PMID:
17621270
[PubMed - indexed for MEDLINE]
17.

Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.

Tang CK, Gong XQ, Moscatello DK, Wong AJ, Lippman ME.

Cancer Res. 2000 Jun 1;60(11):3081-7.

PMID:
10850460
[PubMed - indexed for MEDLINE]
Free Article
19.

ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancer.

Baumgart A, Seidl S, Vlachou P, Michel L, Mitova N, Schatz N, Specht K, Koch I, Schuster T, Grundler R, Kremer M, Fend F, Siveke JT, Peschel C, Duyster J, Dechow T.

Cancer Res. 2010 Jul 1;70(13):5368-78. doi: 10.1158/0008-5472.CAN-09-3763. Epub 2010 Jun 15.

PMID:
20551051
[PubMed - indexed for MEDLINE]
Free Article
20.

Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis.

Xue C, Wyckoff J, Liang F, Sidani M, Violini S, Tsai KL, Zhang ZY, Sahai E, Condeelis J, Segall JE.

Cancer Res. 2006 Jan 1;66(1):192-7. Erratum in: Cancer Res. 2006 Apr 15;66(8):4547.

PMID:
16397232
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk